Leritrelvir
Leritrelvir (RAY1216) is a potent, orally bioavailable SARS-CoV-2 main protease (Mpro) inhibitor. It functions by blocking the cleavage of viral polyproteins, thereby suppressing viral replication. This small molecule is a valuable research tool for in vitro antiviral assays and in vivo studies exploring therapeutic interventions against COVID-19.
Product Specifications
CAS Number
2923310-64-7
Product Name Alternative
SARSCoV, SARS-CoV-2, RAY 1216, RAY1216
Field of Research
Infectious Disease & Virology
Purity
97.42% (May vary between batches)
Smiles
C (N[C@@H] (C[C@H]1C (=O) NCC1) C (C (NC2CCCC2) =O) =O) (=O) [C@H]3N (C ([C@@H] (NC (C (F) (F) F) =O) [C@H]4CCCCC4) =O) C[C@]5 ([C@@]3 (CCC5) [H]) [H]
Molecular Formula
C31H44F3N5O6
Molecular Weight
639.71
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6236779-01 0.1 mL
ATOH1 (Atonal Homolog 1, ATH1, HATH1, MATH-1, BHLHa14) (MaxLight 750)
Sign In for Pricing
View Details MBS6236779-02 5x 0.1 mL
ATOH1 (Atonal Homolog 1, ATH1, HATH1, MATH-1, BHLHa14) (MaxLight 750)
Sign In for Pricing
View Details